Congestive Heart Failure - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics
H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors
Mechanical circulatory support devices for acute right ventricular failure
Sodium-Glucose Co-Transporter 2 Inhibitors and Insights from Biomarker Measurement in Heart Failure Patients
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
SGLT2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced and DAPA-HF Trials
Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine - The ROPA-DOP Trial
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
The multiple causes and treatments of heart failure: focus on genetic and molecular mechanisms and non-pharmacological interventions

Guideline

Apr 01, 2022.

JOURNAL：J Am Coll Cardiol.

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Writing Committee Members, PA Heidenreich, B Bozkurt et al.

2894

Keywords: HF; guideline; 2022

Full Text PDF